These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 17675893)

  • 1. Hypertension and the cardiometabolic syndrome--is it the blood pressure lowering or the blood pressure medication that is important?
    Ferdinand KC
    J Cardiometab Syndr; 2006; 1(1):72-3. PubMed ID: 17675893
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prehypertension and the cardiometabolic syndrome: is there any value in pharmacologic intervention?
    Ferdinand KC
    J Cardiometab Syndr; 2006; 1(2):146-8. PubMed ID: 17679828
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of home blood pressure and ambulatory blood pressure monitoring in decisions of when and whom to treat: recommendations for practicing clinicians.
    Ogedegbe G
    J Cardiometab Syndr; 2006; 1(3):222-4. PubMed ID: 17679827
    [No Abstract]   [Full Text] [Related]  

  • 4. Management of cardiovascular risk in patients with type 2 diabetes mellitus as a component of the cardiometabolic syndrome.
    Ferdinand KC
    J Cardiometab Syndr; 2006; 1(2):133-40. PubMed ID: 17679832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does the metabolic syndrome make blood pressure control more difficult in diabetes?
    Giunti S; Cooper M
    J Hypertens; 2005 Dec; 23(12):2155-6. PubMed ID: 16269956
    [No Abstract]   [Full Text] [Related]  

  • 6. Management of hypertension in children and adolescents with the metabolic syndrome.
    Puri M; Flynn JT
    J Cardiometab Syndr; 2006; 1(4):259-68. PubMed ID: 17679805
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of PREMIER lifestyle modifications on participants with and without the metabolic syndrome.
    Lien LF; Brown AJ; Ard JD; Loria C; Erlinger TP; Feldstein AC; Lin PH; Champagne CM; King AC; McGuire HL; Stevens VJ; Brantley PJ; Harsha DW; McBurnie MA; Appel LJ; Svetkey LP
    Hypertension; 2007 Oct; 50(4):609-16. PubMed ID: 17698724
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The etiology of hypertension in the metabolic syndrome part three: the regulation and dysregulation of blood pressure.
    Sharma V; McNeill JH
    Curr Vasc Pharmacol; 2006 Oct; 4(4):321-48. PubMed ID: 17073701
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is salt sensitivity of blood pressure linked to the cardiometabolic syndrome?
    Weinberger MH
    J Cardiometab Syndr; 2006; 1(3):217-9. PubMed ID: 17679824
    [No Abstract]   [Full Text] [Related]  

  • 10. Effects of intense aerobic exercise and/or antihypertensive medication in individuals with metabolic syndrome.
    Ramirez-Jimenez M; Morales-Palomo F; Ortega JF; Mora-Rodriguez R
    Scand J Med Sci Sports; 2018 Sep; 28(9):2042-2051. PubMed ID: 29771450
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lowering blood pressure for cardiovascular risk reduction: moving the goalposts or spreading the net?
    Webster J
    J Hypertens; 2002 Oct; 20(10):1945-8. PubMed ID: 12359970
    [No Abstract]   [Full Text] [Related]  

  • 12. Treatment of hypertension in metabolic syndrome: implications of recent clinical trials.
    Makaryus AN; Akhrass P; McFarlane SI
    Curr Diab Rep; 2009 Jun; 9(3):229-37. PubMed ID: 19490825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antihypertensive efficacy of zofenopril plus hydrochlorothiazide fixed combination for treatment in metabolic syndrome.
    Malacco E; Omboni S
    Adv Ther; 2007; 24(5):1006-15. PubMed ID: 18029326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypertension in the metabolic syndrome and diabetes: pathogenesis, clinical studies, and treatment.
    Izzo JL
    J Clin Hypertens (Greenwich); 2003; 5(6 Suppl 4):3-10. PubMed ID: 14688488
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systolic hypertension. A specific kind of high blood pressure.
    Mayo Clin Health Lett; 2006 Oct; 24(10):1-3. PubMed ID: 17176518
    [No Abstract]   [Full Text] [Related]  

  • 16. The pressure is on for better blood pressure control.
    Messerschmidt K; ;
    S D J Med; 2003 Jul; 56(7):259-60. PubMed ID: 12901314
    [No Abstract]   [Full Text] [Related]  

  • 17. Update on the metabolic syndrome: hypertension.
    Reynolds K; Wildman RP
    Curr Hypertens Rep; 2009 Apr; 11(2):150-5. PubMed ID: 19278605
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Social adversity experience and blood pressure control following antihypertensive medication use in a community sample of older adults.
    Wainwright NW; Levy S; Pico J; Luben RN; Surtees PG; Khaw KT
    Int J Behav Med; 2014 Jun; 21(3):456-63. PubMed ID: 23677855
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is it time to target prehypertension.
    Whaley-Connell A; Sowers JR
    Cardiovasc Ther; 2010 Dec; 28(6):337-8. PubMed ID: 21050419
    [No Abstract]   [Full Text] [Related]  

  • 20. Adherence to Antihypertensive Treatment and the Blood Pressure-Lowering Effects of Renal Denervation in the Renal Denervation for Hypertension (DENERHTN) Trial.
    Azizi M; Pereira H; Hamdidouche I; Gosse P; Monge M; Bobrie G; Delsart P; Mounier-Véhier C; Courand PY; Lantelme P; Denolle T; Dourmap-Collas C; Girerd X; Michel Halimi J; Zannad F; Ormezzano O; Vaïsse B; Herpin D; Ribstein J; Chamontin B; Mourad JJ; Ferrari E; Plouin PF; Jullien V; Sapoval M; Chatellier G;
    Circulation; 2016 Sep; 134(12):847-57. PubMed ID: 27576780
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.